WASHINGTON (Reuters) - U.S. government researchers launched on Tuesday a pilot project to find all the little genetic changes that cause cancer and hope it can open a whole new world of targeted cancer therapy.
They hope to lay the groundwork for replicating the successes of a few targeted cancer therapies such as Genentech Inc's Herceptin, useful against one type of breast cancer, and Novartis's Gleevec, a pill that revolutionized treatment of chronic myeloid leukemia.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
